LIPAC Trademark

Trademark Overview

On Friday, April 9, 2021, a trademark application was filed for LIPAC with the United States Patent and Trademark Office. The USPTO has given the LIPAC trademark a serial number of 90635513. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, August 26, 2024. This trademark is owned by Lipac Oncology LLC. The LIPAC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, anti-cancer drugs; Pharmaceutical preparations for the treatment of various cancers utilizing liposomal drug delivery technology
lipac

General Information

Serial Number90635513
Word MarkLIPAC
Filing DateFriday, April 9, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, August 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 4, 2022

Trademark Statements

Goods and ServicesPharmaceuticals, namely, anti-cancer drugs; Pharmaceutical preparations for the treatment of various cancers utilizing liposomal drug delivery technology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLIPAC ONCOLOGY, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameLipac Oncology LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025
Party NameLipac Oncology LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPomona, CA 91768

Trademark Events

Event DateEvent Description
Saturday, July 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 13, 2021NEW APPLICATION ENTERED
Tuesday, November 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 30, 2021ASSIGNED TO LIE
Monday, November 29, 2021ASSIGNED TO EXAMINER
Wednesday, December 1, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 1, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 1, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 24, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 23, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, March 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 15, 2023SOU EXTENSION 3 FILED
Wednesday, August 24, 2022SOU EXTENSION 1 FILED
Wednesday, August 24, 2022SOU EXTENSION 1 GRANTED
Friday, August 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 28, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 28, 2023SOU EXTENSION 2 FILED
Tuesday, February 28, 2023SOU EXTENSION 2 GRANTED
Tuesday, August 15, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 15, 2023SOU EXTENSION 3 GRANTED
Thursday, August 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 6, 2024SOU EXTENSION 4 FILED
Tuesday, February 6, 2024SOU EXTENSION 4 GRANTED
Thursday, February 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 26, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 26, 2024SOU EXTENSION 5 FILED
Monday, August 26, 2024SOU EXTENSION 5 GRANTED

Related Keywords

lipac utilizing cancers liposomal drug technology delivery various treatment anti namely